All In MedTech

Device Trial Radar · NCT07764614

Tornier Perform™ Reversed Monopost Study

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

150

Planned (sponsor's estimate)

Start

Oct 22, 2026

Primary completion

Dec 30, 2030

Study completion Aug 30, 2031

Sponsor

Lead sponsor
Stryker Trauma and ExtremitiesPublic (SYK)
Sponsor type
Industry
First posted
Aug 14, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is a Multi-center, Prospective Follow-up, Non-significant risk, Post-Market Clinical Follow-Up (PMCF) study to Evaluate the Safety and Effectiveness of the Tornier Perform™ Reversed MonoPost System.

Conditions

  • Non-inflammatory Degenerative Joint Disease
  • Rhematoid Arthritis
  • Correction of Functional Deformity
  • Fracture of the Humeral Head
  • Traumatic Arthritis
  • Revision of the Devices if Sufficient Bone Stock Remains

Interventions

  • Tornier Perform™ Reversed MonoPostDevice

    The Commercially available Tornier Perform™ Reversed MonoPost Glenoid is intended to replace the glenoid part of the scapulohumeral joint as part of a reverse shoulder prosthesis.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance: American Shoulder and Elbow Surgeons (ASES) score- change in functional ability of the treated shoulderTime frame: from baseline to 2 years

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Eisenhower Health

    Rancho Mirage, California · Recruiting

  • Washington University

    St Louis, Missouri · Recruiting

  • Ohio State University

    Columbus, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.